QADA yields 3.82% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, QADA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QADA + PFE for your $10,000?
QAD Inc. provides cloud-based enterprise software solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers various software solutions, such as customer and service management solutions for manufacturers to acquire new customers; manufacturing solutions, which supports manufacturing business processes; enterprise asset management to manage, maintain, and install capital equipment; supply chain execution solutions that provides tools to support inventory and warehouse management; and financials solutions to manage and control finance and accounting processes. The company also provides demand and supply chain planning solutions to manage various procurement, manufacturing, inventory, distribution, and sales activities; global trade and transportation solutions to manage and optimize network of carriers for shipments; embedded analytics and business intelligence that offers data to measure performance; and internationalization, which supports companies that manufacture and distribute their products worldwide. In addition, it offers customer support and product update services, as well as professional services, including consulting, deployment, training, technical, development, and integration. The company markets its products through direct and indirect sales channels; and distributors and sales agents. It serves automotive, life sciences, consumer products, food and beverage, high technology, and industrial products manufacturing companies. QAD Inc. was founded in 1979 and is headquartered in Santa Barbara, California.
Full QADA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.